Actively Recruiting
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality
Led by Sorlandet Hospital HF · Updated on 2023-12-29
300
Participants Needed
1
Research Sites
308 weeks
Total Duration
On this page
Sponsors
S
Sorlandet Hospital HF
Lead Sponsor
S
South-Eastern Norway Regional Health Authority
Collaborating Sponsor
AI-Summary
What this Trial Is About
The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.
CONDITIONS
Official Title
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients
- Large vessel occlusion stroke
You will not qualify if you...
- Intracranial hemorrhage, tumor, aneurism or vascular malformation in the stroke area
- More than 24 hours after stroke onset
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sørlandet Hospital Health Trust
Kristiansand, Agder, Norway, 4604
Actively Recruiting
Research Team
O
Olav Søvik, MD
CONTACT
P
Per Kristian Hyldmo, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here